These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26188827)

  • 1. Peri-procedural myocardial infarction following percutaneous coronary intervention as defined by the Universal Definition predicts increased mortality at 2 years.
    Liou K; Ng B; Isbister J; Kellar P; Jepson N; Pitney M; Ooi SY
    Int J Cardiol; 2015 Nov; 199():96-8. PubMed ID: 26188827
    [No Abstract]   [Full Text] [Related]  

  • 2. Stress Testing After Percutaneous Coronary Intervention in the Veterans Affairs HealthCare System: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    Bradley SM; Hess E; Winchester DE; Sussman JB; Aggarwal V; Maddox TM; Barón AE; Rumsfeld JS; Ho PM
    Circ Cardiovasc Qual Outcomes; 2015 Sep; 8(5):486-92. PubMed ID: 26198400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Peri-procedural Myocardial Infarction in the Era of High Sensitivity Troponin: A Validation of the Joint ACCF/AHA/ESC/WHF Universal Definition of Type 4a Myocardial Infarction with High Sensitivity Troponin T.
    Liou K; Jepson N; Kellar P; Ng B; Isbister J; Giles R; Friedman D; Allan R; Lau A; Pitney M; Ooi SY
    Heart Lung Circ; 2015 Jul; 24(7):673-81. PubMed ID: 25697382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the Framingham Risk Score in predicting secondary events in patients following percutaneous coronary intervention: A time-trend analysis.
    Sara JD; Lennon RJ; Gulati R; Singh M; Holmes DR; Lerman LO; Lerman A
    Am Heart J; 2016 Feb; 172():115-28. PubMed ID: 26856223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention.
    Park DW; Kim YH; Yun SC; Ahn JM; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Eur Heart J; 2013 Jun; 34(22):1662-9. PubMed ID: 23404537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of elderly patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011: A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) registry.
    Velders MA; James SK; Libungan B; Sarno G; Fröbert O; Carlsson J; Schalij MJ; Albertsson P; Lagerqvist B
    Am Heart J; 2014 May; 167(5):666-73. PubMed ID: 24766976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
    Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
    Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
    Herrmann J; Lennon RJ; Barsness GW; Sandhu GS; Gulati R; Best PJ; Sorajja P; Bresnahan JF; Mathew V; Bell MR; Prasad A
    Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.
    Chen SL; Zhang JJ; Ye F; Tian NL; Sheiban I; Jepson N; Paiboon C; Sansoto T; Kwan TW; Wen SY; Wang HC; Jiang TM; Wang Y; Chen LL; Qiu CG; Zhang YJ; Chen MX; De Maria A
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():696-705. PubMed ID: 25631678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midterm follow-up of patients with perioperative myocardial infarction after coronary artery bypass surgery: clinical significance of different treatment strategies.
    Alexiou K; Wilbring M; Koch C; Kappert U; Tugtekin S; Matschke K
    Thorac Cardiovasc Surg; 2012 Oct; 60(7):452-61. PubMed ID: 22547303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedure-related bleeding in elective percutaneous coronary interventions.
    Ndrepepa G; Stephan T; Fiedler KA; Guerra E; Kufner S; Kastrati A
    Eur J Clin Invest; 2015 Mar; 45(3):263-73. PubMed ID: 25645583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of preinfarction angina pectoris on long-term survival in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
    Taniguchi T; Shiomi H; Toyota T; Morimoto T; Akao M; Nakatsuma K; Ono K; Makiyama T; Shizuta S; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Horie M; Kimura T
    Am J Cardiol; 2014 Oct; 114(8):1179-86. PubMed ID: 25159235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.
    Leonardi S; Thomas L; Neely ML; Tricoci P; Lopes RD; White HD; Armstrong PW; Giugliano RP; Antman EM; Califf RM; Newby LK; Mahaffey KW
    J Am Coll Cardiol; 2012 Dec; 60(22):2296-304. PubMed ID: 23122801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
    Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
    Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac troponin release following hybrid coronary revascularization versus off-pump coronary artery bypass surgery.
    Harskamp RE; Abdelsalam M; Lopes RD; Boga G; Hirji S; Krishnan M; Kiljanek L; Mumtaz M; Tijssen JG; McCarty C; de Winter RJ; Bachinsky WB
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1008-12. PubMed ID: 25217621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between preoperative renal dysfunction and cardiovascular events (stroke, myocardial infarction, or heart failure or death) within three months of isolated coronary artery bypass grafting.
    Holzmann MJ; Sartipy U
    Am J Cardiol; 2013 Nov; 112(9):1342-6. PubMed ID: 23870631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial).
    Collet JP; Huber K; Cohen M; Zeymer U; Goldstein P; Pollack C; Silvain J; Henry P; Varenne O; Carrié D; Coste P; Angioi M; Le Breton H; Cayla G; Elhadad S; Teiger E; Filippi E; Aout M; Vicaut E; Montalescot G;
    Am J Cardiol; 2013 Nov; 112(9):1367-72. PubMed ID: 24012033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis after maternal placental events and revascularization: PAMPER study.
    Ray JG; Booth GL; Alter DA; Vermeulen MJ
    Am J Obstet Gynecol; 2016 Jan; 214(1):106.e1-106.e14. PubMed ID: 26283454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.